geneType™ Multi Test

A combination of geneType™ tests for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type 2 diabetes in a single test.

Know your risk of a serious disease to tailor a personalised prevention plan with your medical practitioner.

Request more information

Our pipeline

We have a strong pipeline of tests covering a wide range of serious conditions that are currently in various stages development, accreditation and approval.

Phase 2 launch of the geneType™ Multi-Risk Test

Introducing Melanoma, Pancreatic Cancer and Atrial Fibrillation

Expanding our capability, introducing NIPT and Carrier testing

Development of Epigenetics Division

Phase 1 Methylation tests
Phase 2 Mutation tests

Accredited For Compliance With NPAAC Standards And ISO 15189